Trials / Recruiting
RecruitingNCT03039309
Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom
Endoscopic Submucosal Dissection in the Treatment of Early Gastrointestinal Neoplasia: A UK Cohort Study to Assess Effectiveness and Safety
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Portsmouth Hospitals NHS Trust · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multicentre cohort study on the use of endoscopic submucosal dissection for the treatment of early gastrointestinal neoplasia.
Detailed description
Data will be collected from participating centres on en bloc resection, curative resection, R0 resection and complications/adverse events over a 2 year follow up period. Demographic details on the patients included in the study will be captured alongside details on the size and location of their early gastrointestinal dysplastic/neoplastic lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endoscopic Submucosal Dissection | Endoscopic submucosal dissection is an endoscopic resection technique that utilises an endoscopic knife to remove lesions within the gastrointestinal tract in an en bloc fashion. |
Timeline
- Start date
- 2016-08-05
- Primary completion
- 2026-08-04
- Completion
- 2028-08-04
- First posted
- 2017-02-01
- Last updated
- 2025-05-31
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03039309. Inclusion in this directory is not an endorsement.